Reporting Manager
Atlas Venture Associates XII, L.P.
Symbol
JBIO
Disclosed Ownership
51,406 shares
Ownership
0.2%
Form type
SCHEDULE 13D/A
Filing time
30 Apr 2025, 16:29:11 UTC
Date of event
28 Apr 2025

Sponsored

Quoteable Key Fact

"Atlas Venture Fund XII, L.P. disclosed 0.2% ownership in JADE BIOSCIENCES, INC. Common Stock (JBIO) on 28 Apr 2025."

Quick Takeaways

  • Atlas Venture Fund XII, L.P. filed SCHEDULE 13D/A for JADE BIOSCIENCES, INC. Common Stock (JBIO).
  • Disclosed ownership: 0.2%.
  • Date of event: 28 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 30 Apr 2025, 16:29.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Atlas Venture Fund XII, L.P. 0.2% 50,992 0 50,992 /s/ Ommer Chohan By: Atlas Venture Associates XII, L.P., its general partner, By: Atlas Venture Associates XII, LLC, its general partner, By: Ommer Chohan, its CFO 0001812049
Atlas Venture Associates XII, L.P. 0.2% 51,406 0 51,406 /s/ Ommer Chohan By: Atlas Venture Associates XII, LLC, its general partner, By: Ommer Chohan, its CFO 0001845875
Atlas Venture Associates XII, LLC 0.2% 51,406 0 51,406 /s/ Ommer Chohan Ommer Chohan, CFO 0001845871